At its investor day event on Wednesday, BioMarin BMRN unveiled its long-term plans for growth, including potential drug approvals and revenue guidance over the next 10 years. Management also updated ...
Source LinkAt its investor day event on Wednesday, BioMarin BMRN unveiled its long-term plans for growth, including potential drug approvals and revenue guidance over the next 10 years. Management also updated ...
Source Link
Comments